{"transactions":[{"id":1034168,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T20:05:59.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":23605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 17,621 shares vested in full upon the date of grant and options to purchase 5,984 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":23605,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":23605},"source":{"system":"sec-edgar","filing":"0001844060-25-000003","document":"wk-form4_1758571556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000184406025000003/wk-form4_1758571556.xml","form_type":"4"}},{"id":1034169,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":44226,"kind":"person","name":"SIMPSON CAMILLA V","position":1,"cik":"0001822557","reported_name":"SIMPSON CAMILLA V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T20:05:53.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":23605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 17,621 shares vested in full upon the date of grant and options to purchase 5,984 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":23605,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":23605},"source":{"system":"sec-edgar","filing":"0001822557-25-000005","document":"wk-form4_1758571550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822557/000182255725000005/wk-form4_1758571550.xml","form_type":"4"}},{"id":1034167,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T20:05:47.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":43222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":43222,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":43222},"source":{"system":"sec-edgar","filing":"0001971423-25-000003","document":"wk-form4_1758571544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000197142325000003/wk-form4_1758571544.xml","form_type":"4"}},{"id":1034164,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75052,"kind":"person","name":"Hertz Walter Marc","position":1,"cik":"0001971132","reported_name":"Hertz Walter Marc","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T20:05:36.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":103067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 76,469 shares vested in full upon the date of grant and options to purchase 26,598 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":103067,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":103067},"source":{"system":"sec-edgar","filing":"0001971132-25-000006","document":"wk-form4_1758571533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000197113225000006/wk-form4_1758571533.xml","form_type":"4"}},{"id":1034246,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T16:06:10.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":43222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299  shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":43222,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":43222},"source":{"system":"sec-edgar","filing":"0001398278-25-000004","document":"wk-form4_1758571567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000139827825000004/wk-form4_1758571567.xml","form_type":"4"}},{"id":1034221,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T16:06:04.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":39897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 29,293 shares vested in full upon the date of grant and options to purchase 9,974 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":39897,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":39897},"source":{"system":"sec-edgar","filing":"0001602459-25-000004","document":"wk-form4_1758571561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000160245925000004/wk-form4_1758571561.xml","form_type":"4"}},{"id":1034186,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75055,"kind":"person","name":"Rongen Roelof","position":1,"cik":"0001698966","reported_name":"Rongen Roelof","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T16:05:41.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":23605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 17,621 shares vested in full upon the date of grant and options to purchase 5,984 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":23605,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":23605},"source":{"system":"sec-edgar","filing":"0001698966-25-000004","document":"wk-form4_1758571538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698966/000169896625000004/wk-form4_1758571538.xml","form_type":"4"}},{"id":1054267,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75052,"kind":"person","name":"Hertz Walter Marc","position":1,"cik":"0001971132","reported_name":"Hertz Walter Marc","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T12:25:26.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":26688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 17,828 shares vested in full upon the date of grant and options to purchase 8,860 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":26688,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":26688},"source":{"system":"sec-edgar","filing":"0001824293-25-000144","document":"wk-form4_1756297522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000144/wk-form4_1756297522.xml","form_type":"4"}},{"id":1054266,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T12:25:12.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":5994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 4,044 shares vested in full upon the date of grant and options to purchase 1,950 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":5994,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":5994},"source":{"system":"sec-edgar","filing":"0001824293-25-000142","document":"wk-form4_1756297508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000142/wk-form4_1756297508.xml","form_type":"4"}},{"id":1054265,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T12:24:57.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":11854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":11854,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":11854},"source":{"system":"sec-edgar","filing":"0001824293-25-000140","document":"wk-form4_1756297493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000140/wk-form4_1756297493.xml","form_type":"4"}},{"id":1054268,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":44226,"kind":"person","name":"SIMPSON CAMILLA V","position":1,"cik":"0001822557","reported_name":"SIMPSON CAMILLA V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T12:24:51.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":5994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 4,044 shares vested in full upon the date of grant and options to purchase 1,950 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":5994,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":5994},"source":{"system":"sec-edgar","filing":"0001824293-25-000139","document":"wk-form4_1756297487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822557/000182429325000139/wk-form4_1756297487.xml","form_type":"4"}},{"id":1054303,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T08:25:19.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 6,933 shares vested in full upon the date of grant and options to purchase 3,343 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":10276,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":10276},"source":{"system":"sec-edgar","filing":"0001824293-25-000143","document":"wk-form4_1756297514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000143/wk-form4_1756297514.xml","form_type":"4"}},{"id":1054292,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75055,"kind":"person","name":"Rongen Roelof","position":1,"cik":"0001698966","reported_name":"Rongen Roelof","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T08:25:04.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":5994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 4,044 shares vested in full upon the date of grant and options to purchase 1,950 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":5994,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":5994},"source":{"system":"sec-edgar","filing":"0001824293-25-000141","document":"wk-form4_1756297500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698966/000182429325000141/wk-form4_1756297500.xml","form_type":"4"}},{"id":1054327,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T08:24:44.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":11854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":11854,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":11854},"source":{"system":"sec-edgar","filing":"0001824293-25-000138","document":"wk-form4_1756297480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000182429325000138/wk-form4_1756297480.xml","form_type":"4"}},{"id":1066077,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":44226,"kind":"person","name":"SIMPSON CAMILLA V","position":1,"cik":"0001822557","reported_name":"SIMPSON CAMILLA V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T20:58:44.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":4527,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001824293-25-000119","document":"wk-form4_1755205119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822557/000182429325000119/wk-form4_1755205119.xml","form_type":"4"}},{"id":1066075,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T20:58:34.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":4527,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001824293-25-000118","document":"wk-form4_1755205110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000118/wk-form4_1755205110.xml","form_type":"4"}},{"id":1066106,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75055,"kind":"person","name":"Rongen Roelof","position":1,"cik":"0001698966","reported_name":"Rongen Roelof","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T16:58:26.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":4527,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001824293-25-000117","document":"wk-form4_1755205102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698966/000182429325000117/wk-form4_1755205102.xml","form_type":"4"}},{"id":1066120,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T16:58:19.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":7545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7545,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":7545},"source":{"system":"sec-edgar","filing":"0001824293-25-000116","document":"wk-form4_1755205093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000116/wk-form4_1755205093.xml","form_type":"4"}},{"id":1295287,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T22:58:17.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":43319,"price":0.6857,"value":29703.8383,"ownership":{"direct":true},"balance_after":43319,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":43319},"source":{"system":"sec-edgar","filing":"0001824293-25-000034","document":"wk-form4_1737759490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000034/wk-form4_1737759490.xml","form_type":"4"}},{"id":1295285,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75052,"kind":"person","name":"Hertz Walter Marc","position":1,"cik":"0001971132","reported_name":"Hertz Walter Marc","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T22:58:06.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":129730,"price":0.6857,"value":88955.861,"ownership":{"direct":true},"balance_after":129730,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":129730},"source":{"system":"sec-edgar","filing":"0001824293-25-000033","document":"wk-form4_1737759479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000033/wk-form4_1737759479.xml","form_type":"4"}},{"id":1295292,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":44226,"kind":"person","name":"SIMPSON CAMILLA V","position":1,"cik":"0001822557","reported_name":"SIMPSON CAMILLA V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T22:57:55.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":30297,"price":0.6857,"value":20774.6529,"ownership":{"direct":true},"balance_after":30297,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":30297},"source":{"system":"sec-edgar","filing":"0001824293-25-000032","document":"wk-form4_1737759469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822557/000182429325000032/wk-form4_1737759469.xml","form_type":"4"}},{"id":1295286,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T22:57:45.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":30297,"price":0.6857,"value":20774.6529,"ownership":{"direct":true},"balance_after":30297,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":30297},"source":{"system":"sec-edgar","filing":"0001824293-25-000031","document":"wk-form4_1737759458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000031/wk-form4_1737759458.xml","form_type":"4"}},{"id":1295381,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T17:58:28.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":43319,"price":0.6857,"value":29703.8383,"ownership":{"direct":true},"balance_after":43319,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":43319},"source":{"system":"sec-edgar","filing":"0001824293-25-000035","document":"wk-form4_1737759502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000182429325000035/wk-form4_1737759502.xml","form_type":"4"}},{"id":1295355,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T17:57:34.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":51937,"price":0.6857,"value":35613.2009,"ownership":{"direct":true},"balance_after":51937,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":51937},"source":{"system":"sec-edgar","filing":"0001824293-25-000030","document":"wk-form4_1737759448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000030/wk-form4_1737759448.xml","form_type":"4"}},{"id":1295328,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75055,"kind":"person","name":"Rongen Roelof","position":1,"cik":"0001698966","reported_name":"Rongen Roelof","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T17:57:23.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":30297,"price":0.6857,"value":20774.6529,"ownership":{"direct":true},"balance_after":30297,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":30297},"source":{"system":"sec-edgar","filing":"0001824293-25-000029","document":"wk-form4_1737759436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698966/000182429325000029/wk-form4_1737759436.xml","form_type":"4"}},{"id":1773096,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-26T16:08:55.000Z","date":"2023-09-22","kind":"grant","planned":false,"acquired":true,"shares":83333,"price":1.52,"value":126666.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 36 equal monthly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":83333,"derivative":{"exercise_price":1.52,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001824293-23-000163","document":"wk-form4_1695758927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000182429323000163/wk-form4_1695758927.xml","form_type":"4"}},{"id":1808113,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":44226,"kind":"person","name":"SIMPSON CAMILLA V","position":1,"cik":"0001822557","reported_name":"SIMPSON CAMILLA V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-14T20:07:42.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":34483,"price":2.9,"value":100000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant."}],"balance_after":34483,"derivative":{"exercise_price":2.9,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001824293-23-000154","document":"wk-form4_1692043648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822557/000182429323000154/wk-form4_1692043648.xml","form_type":"4"}},{"id":1808105,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-14T20:06:20.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":34483,"price":2.9,"value":100000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant."}],"balance_after":34483,"derivative":{"exercise_price":2.9,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001824293-23-000152","document":"wk-form4_1692043540.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000152/wk-form4_1692043540.xml","form_type":"4"}},{"id":1808195,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-14T16:10:06.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":34483,"price":2.9,"value":100000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant."}],"balance_after":34483,"derivative":{"exercise_price":2.9,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001824293-23-000156","document":"wk-form4_1692043784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429323000156/wk-form4_1692043784.xml","form_type":"4"}},{"id":1808154,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75055,"kind":"person","name":"Rongen Roelof","position":1,"cik":"0001698966","reported_name":"Rongen Roelof","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-14T16:07:02.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":34483,"price":2.9,"value":100000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant."}],"balance_after":34483,"derivative":{"exercise_price":2.9,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001824293-23-000153","document":"wk-form4_1692043604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698966/000182429323000153/wk-form4_1692043604.xml","form_type":"4"}},{"id":1914701,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75052,"kind":"person","name":"Hertz Walter Marc","position":1,"cik":"0001971132","reported_name":"Hertz Walter Marc","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-24T22:30:14.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":385510,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 10,307,793 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 10,307,793 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."}],"balance_after":385510,"source":{"system":"sec-edgar","filing":"0001824293-23-000104","document":"wf-form4_168237539956604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000104/wf-form4_168237539956604.xml","form_type":"4"}},{"id":1914702,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-04-24T22:29:39.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":172189,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."}],"balance_after":172189,"source":{"system":"sec-edgar","filing":"0001824293-23-000102","document":"wf-form4_168237536636728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000102/wf-form4_168237536636728.xml","form_type":"4"}},{"id":1914734,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":114197,"kind":"person","name":"Agro Albert","position":1,"cik":"0001661357","reported_name":"Agro Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-24T18:29:56.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":172189,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."}],"balance_after":172189,"source":{"system":"sec-edgar","filing":"0001824293-23-000103","document":"wf-form4_168237538206040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661357/000182429323000103/wf-form4_168237538206040.xml","form_type":"4"}},{"id":2084718,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":30936,"kind":"person","name":"Thorell Marella","position":1,"cik":"0001826323","reported_name":"Thorell Marella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T21:26:39.000Z","date":"2022-12-13","kind":"other","acquired":false,"shares":28517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of unvested restricted stock units granted on July 1, 2022."}],"balance_after":9506,"source":{"system":"sec-edgar","filing":"0001824293-22-000082","document":"wf-form4_167113958127044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000082/wf-form4_167113958127044.xml","form_type":"4"}},{"id":2211171,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":30936,"kind":"person","name":"Thorell Marella","position":1,"cik":"0001826323","reported_name":"Thorell Marella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T18:03:57.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":38023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in four (4) equal quarterly installments such that the RSU will be fully vested on the first (1st) anniversary of the date of grant, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of Vallon Pharmaceuticals, Inc."}],"balance_after":38023,"source":{"system":"sec-edgar","filing":"0001824293-22-000061","document":"wf-form4_165713062186980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000061/wf-form4_165713062186980.xml","form_type":"4"}},{"id":2235229,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T17:32:20.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7500,"derivative":{"exercise_price":0.51,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001824293-22-000056","document":"wf-form4_165488232409421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000056/wf-form4_165488232409421.xml","form_type":"4"}},{"id":2235227,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":30936,"kind":"person","name":"Thorell Marella","position":1,"cik":"0001826323","reported_name":"Thorell Marella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T17:31:44.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7500,"derivative":{"exercise_price":0.51,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001824293-22-000054","document":"wf-form4_165488229138396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000054/wf-form4_165488229138396.xml","form_type":"4"}},{"id":2235292,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T13:32:00.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7500,"derivative":{"exercise_price":0.51,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001824293-22-000055","document":"wf-form4_165488230708266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000182429322000055/wf-form4_165488230708266.xml","form_type":"4"}},{"id":2341221,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":45755,"kind":"person","name":"Chhabra Meenu","position":1,"cik":"0001534200","reported_name":"Chhabra Meenu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T22:02:05.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":15000,"price":7.67,"value":115050.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock options vests in 24 equal monthly installments such that the stock options shall be fully vested as of the second annual anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":7.67,"expiration_date":"2032-02-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001824293-22-000015","document":"wf-form4_164686330942029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534200/000182429322000015/wf-form4_164686330942029.xml","form_type":"4"}},{"id":2364151,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T22:04:11.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":61000,"price":5.63,"value":343430.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":61000,"derivative":{"exercise_price":5.63,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001824293-22-000011","document":"wf-form4_164617221607889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000011/wf-form4_164617221607889.xml","form_type":"4"}},{"id":2364514,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T17:03:28.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":50000,"price":5.63,"value":281500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":5.63,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001824293-22-000010","document":"wf-form4_164617217734478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000182429322000010/wf-form4_164617217734478.xml","form_type":"4"}},{"id":2680544,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-04T16:06:09.000Z","date":"2021-06-04","kind":"purchase","acquired":true,"shares":1508,"price":4.08,"value":6152.64,"ownership":{"direct":true},"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001104659-21-076998","document":"tm2118823d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000110465921076998/tm2118823d1_4.xml","form_type":"4"}},{"id":2680543,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-04T16:06:09.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":1085,"price":4.05,"value":4394.25,"ownership":{"direct":true},"balance_after":4742,"source":{"system":"sec-edgar","filing":"0001104659-21-076998","document":"tm2118823d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000110465921076998/tm2118823d1_4.xml","form_type":"4"}},{"id":2680542,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-04T16:06:09.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":3657,"price":4,"value":14628.0,"ownership":{"direct":true},"balance_after":3657,"source":{"system":"sec-edgar","filing":"0001104659-21-076998","document":"tm2118823d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000110465921076998/tm2118823d1_4.xml","form_type":"4"}},{"id":2692554,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:37:49.000Z","date":"2021-05-26","kind":"purchase","acquired":true,"shares":6800,"price":4.5,"value":30600.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001104659-21-073495","document":"tm2117820-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921073495/tm2117820-1_4.xml","form_type":"4"}},{"id":2692553,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:37:49.000Z","date":"2021-05-25","kind":"purchase","acquired":true,"shares":10700,"price":3.85,"value":41195.0,"ownership":{"direct":true},"balance_after":10700,"source":{"system":"sec-edgar","filing":"0001104659-21-073495","document":"tm2117820-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921073495/tm2117820-1_4.xml","form_type":"4"}},{"id":2707007,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:23.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021."}],"balance_after":10204,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":10204},"source":{"system":"sec-edgar","filing":"0001104659-21-068838","document":"tm2116776-6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068838/tm2116776-6_4.xml","form_type":"4"}},{"id":2707006,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:23.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-068838","document":"tm2116776-6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068838/tm2116776-6_4.xml","form_type":"4"}},{"id":2707005,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":139277,"kind":"person","name":"Levi Ofir","position":1,"cik":"0001843598","reported_name":"Levi Ofir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:07.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-21-068837","document":"tm2116776-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068837/tm2116776-5_4.xml","form_type":"4"}},{"id":2707004,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":139277,"kind":"person","name":"Levi Ofir","position":1,"cik":"0001843598","reported_name":"Levi Ofir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:07.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021."}],"balance_after":15000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-068837","document":"tm2116776-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068837/tm2116776-5_4.xml","form_type":"4"}},{"id":2707003,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":139276,"kind":"person","name":"Toren Penny","position":1,"cik":"0001843596","reported_name":"Toren Penny","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regul Affairs & Prog Mgmt"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:06:16.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-068831","document":"tm2116776-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068831/tm2116776-3_4.xml","form_type":"4"}},{"id":2707002,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:06:03.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-068828","document":"tm2116776-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068828/tm2116776-2_4.xml","form_type":"4"}},{"id":2707100,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T16:09:13.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":14286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021."}],"balance_after":14286,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":14286},"source":{"system":"sec-edgar","filing":"0001104659-21-068839","document":"tm2116776-7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921068839/tm2116776-7_4.xml","form_type":"4"}},{"id":2707099,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T16:09:13.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-068839","document":"tm2116776-7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921068839/tm2116776-7_4.xml","form_type":"4"}},{"id":2707333,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75057,"kind":"person","name":"Kelly Leanne","position":1,"cik":"0001398278","reported_name":"Kelly Leanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T16:07:59.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant."}],"balance_after":70000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-21-068835","document":"tm2116776-4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398278/000110465921068835/tm2116776-4_4.xml","form_type":"4"}},{"id":2862066,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T23:02:26.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":47063,"price":6.4,"value":301203.2,"ownership":{"direct":false,"nature":"By SALMON Pharma GmbH"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021,  filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001104659-21-022190","document":"tm214979-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022190/tm214979-8_4seq1.xml","form_type":"4"}},{"id":2862065,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":142685,"kind":"organization","name":"SALMON Pharma GmbH","position":1,"cik":"0001843677","reported_name":"SALMON Pharma GmbH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T23:02:17.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":47063,"price":6.4,"value":301203.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021,  filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended."}],"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001104659-21-022188","document":"tm214979-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022188/tm214979-10_4seq1.xml","form_type":"4"}},{"id":2862064,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":30936,"kind":"person","name":"Thorell Marella","position":1,"cik":"0001826323","reported_name":"Thorell Marella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T23:01:17.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 24 equal monthly installments such that the stock option shall be fully vested as of the second anniversary of the consummation of the initial public offering of the company's common stock."}],"balance_after":15000,"derivative":{"exercise_price":8,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-022187","document":"tm214979d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022187/tm214979d7_4seq1.xml","form_type":"4"}},{"id":2862062,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-12T23:00:27.000Z","date":"2021-02-12","kind":"purchase","acquired":true,"shares":1000,"price":8,"value":8000.0,"ownership":{"direct":true},"balance_after":8843,"source":{"system":"sec-edgar","filing":"0001104659-21-022185","document":"tm214979-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022185/tm214979-9_4seq1.xml","form_type":"4"}},{"id":2862061,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75054,"kind":"person","name":"Baker David Charles","position":1,"cik":"0001844060","reported_name":"Baker David Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-12T23:00:27.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":7843,"price":6.4,"value":50195.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended."}],"balance_after":7843,"source":{"system":"sec-edgar","filing":"0001104659-21-022185","document":"tm214979-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022185/tm214979-9_4seq1.xml","form_type":"4"}}]}